Wells Fargo’s Bio-Rad Laboratories Class B BIO.B Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $41.2K | Hold |
170
| – | – | ﹤0.01% | 5154 |
|
2025
Q1 | $41.1K | Hold |
170
| – | – | ﹤0.01% | 5009 |
|
2024
Q4 | $55.4K | Hold |
170
| – | – | ﹤0.01% | 4960 |
|
2024
Q3 | $55.5K | Hold |
170
| – | – | ﹤0.01% | 4905 |
|
2024
Q2 | $48.2K | Hold |
170
| – | – | ﹤0.01% | 4943 |
|
2024
Q1 | $56.5K | Hold |
170
| – | – | ﹤0.01% | 4830 |
|
2023
Q4 | $54.5K | Hold |
170
| – | – | ﹤0.01% | 4828 |
|
2023
Q3 | $60.4K | Hold |
170
| – | – | ﹤0.01% | 4739 |
|
2023
Q2 | $63.1K | Buy |
170
+114
| +204% | +$42.3K | ﹤0.01% | 5035 |
|
2023
Q1 | $26K | Hold |
56
| – | – | ﹤0.01% | 5219 |
|
2022
Q4 | $22.7K | Hold |
56
| – | – | ﹤0.01% | 4890 |
|
2022
Q3 | $23K | Hold |
56
| – | – | ﹤0.01% | 4996 |
|
2022
Q2 | $26K | Hold |
56
| – | – | ﹤0.01% | 5028 |
|
2022
Q1 | $33K | Hold |
56
| – | – | ﹤0.01% | 5488 |
|
2021
Q4 | $42K | Hold |
56
| – | – | ﹤0.01% | 5579 |
|
2021
Q3 | $42K | Hold |
56
| – | – | ﹤0.01% | 5383 |
|
2021
Q2 | $36K | Hold |
56
| – | – | ﹤0.01% | 5362 |
|
2021
Q1 | $32K | Hold |
56
| – | – | ﹤0.01% | 5650 |
|
2020
Q4 | $33K | Hold |
56
| – | – | ﹤0.01% | 5501 |
|
2020
Q3 | $29K | Hold |
56
| – | – | ﹤0.01% | 5390 |
|
2020
Q2 | $25K | Hold |
56
| – | – | ﹤0.01% | 5352 |
|
2020
Q1 | $20K | Hold |
56
| – | – | ﹤0.01% | 5336 |
|
2019
Q4 | $21K | Hold |
56
| – | – | ﹤0.01% | 5438 |
|
2019
Q3 | $19K | Hold |
56
| – | – | ﹤0.01% | 5455 |
|
2019
Q2 | $17K | Hold |
56
| – | – | ﹤0.01% | 5454 |
|
2019
Q1 | $17K | Hold |
56
| – | – | ﹤0.01% | 5450 |
|
2018
Q4 | $13K | Buy |
+56
| New | +$13K | ﹤0.01% | 5508 |
|